Table 3

Correlations of connexin and Ki67 proliferation marker expression with clinicipathological parameters
Cx43 Cx26 Cx32 Cx46 Ki67
pre post pre post pre post pre post pre post
ER pre 0.30 x ns x ns x ns x −0.46 −0.35
ER post 0.36 ns ns ns ns ns ns ns −0.40 −0.38
PR pre 0.34 x ns x ns x ns x −0.45 x
PR post 0.33 ns ns ns ns ns ns ns −0.52 ns
HER2 pre −0.27 x ns x 0.31 x ns x ns x
HER2 post ns ns ns ns ns ns ns ns ns 0.26
cT pre 0.29 x ns x ns x ns x ns x
cN pre ns x ns x ns x ns x ns x
pT post ns ns ns ns −0.29 ns ns ns ns ns
pN post ns ns ns ns ns ns 0.39 0.32 ns ns
grade pre ns x ns x ns x ns x ns ns
Ki67 pre ns x ns x ns x −0.29 x x 0.46
Ki67 post ns ns ns ns ns 0.46 ns ns 0.46 x

ns: not significant; x: not relevant; pre: prior to chemotherapy; post: after chemotherapy.

Teleki et al.

Teleki et al. BMC Cancer 2013 13:50   doi:10.1186/1471-2407-13-50

Open Data